Scholar Rock Holding (SRRK) Other Non-Current Assets (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Other Non-Current Assets came in at $4.6 million in Q1 2026, up 90.65% year-on-year from $2.4 million in Q1 2025, and up 42.03% quarter-over-quarter from $3.2 million in Q4 2025.

Scholar Rock Holding (SRRK) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $4.6 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 90.65% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 90.65% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 34.23% from the prior year.
  • Other Non-Current Assets grew to $4.6 million in Q1 2026 per SRRK's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.6 million in Q1 2026 and bottomed at $1.7 million in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $2.5 million (2022), against an average of $2.6 million.
  • Across the five-year window, Other Non-Current Assets sank 31.18% in 2022 and jumped 90.65% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $1.7 million in 2022, then soared by 40.02% to $2.4 million in 2023, then changed by 0.0% to $2.4 million in 2024, then jumped by 34.23% to $3.2 million in 2025, then soared by 42.03% to $4.6 million in 2026.
  • Per Business Quant, the three latest SRRK Other Non-Current Assets figures stand at $4.6 million (Q1 2026), $3.2 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 4.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.59 Mn
Dec 31, 2025 3.23 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.41 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.41 Mn
Mar 31, 2024 2.41 Mn
Dec 31, 2023 2.41 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 2.61 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 1.72 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.50 Mn